Sepsis: a review of advances in management

J Rello, F Valenzuela-Sánchez, M Ruiz-Rodriguez… - Advances in …, 2017 - Springer
Infections represent a common health problem in people of all ages. Usually, the response
given to them is appropriate and so little treatment is needed. Sometimes, however, the …

Biomarkers for sepsis

C Henriquez-Camacho, J Losa - BioMed research international, 2014 - Wiley Online Library
Bloodstream infections are a major concern because of high levels of antibiotic consumption
and of the increasing prevalence of antimicrobial resistance. Bacteraemia is identified in a …

Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment

M Sandquist, HR Wong - Expert review of clinical immunology, 2014 - Taylor & Francis
Biomarkers have great potential to improve the diagnosis and treatment of sepsis. The
available literature supports the potential utility of sTREM-1, IL-27, suPAR, neutrophil CD64 …

Predicting and managing sepsis in burn patients: current perspectives

O Nunez Lopez, J Cambiaso-Daniel… - … and clinical risk …, 2017 - Taylor & Francis
Modern burn care has led to unprecedented survival rates in burn patients whose injuries
were fatal a few decades ago. Along with improved survival, new challenges have emerged …

Host biomarkers for distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review

AJ Kapasi, S Dittrich, IJ González, TC Rodwell - PloS one, 2016 - journals.plos.org
Background In resource limited settings acute febrile illnesses are often treated empirically
due to a lack of reliable, rapid point-of-care diagnostics. This contributes to the …

Advances in antibiotic therapy in the critically ill

JL Vincent, M Bassetti, B François, G Karam, J Chastre… - Critical Care, 2016 - Springer
Infections occur frequently in critically ill patients and their management can be challenging
for various reasons, including delayed diagnosis, difficulties identifying causative …

Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis

MA Hincu, GI Zonda, GD Stanciu, D Nemescu… - Children, 2020 - mdpi.com
Neonatal early-onset sepsis (EOS) is defined as an invasive infection that occurs in the first
72 h of life. The incidence of EOS varies from 0.5–2% live births in developed countries, up …

Calprotectin, a new biomarker for diagnosis of acute respiratory infections

A Havelka, K Sejersen, P Venge, K Pauksens… - Scientific reports, 2020 - nature.com
Respiratory tract infections require early diagnosis and adequate treatment. With the
antibiotic overuse and increment in antibiotic resistance there is an increased need to …

[HTML][HTML] Biomarker-guided antibiotic therapy—strengths and limitations

D Nora, J Salluh, I Martin-Loeches… - Annals of translational …, 2017 - ncbi.nlm.nih.gov
Biomarkers as C-reactive protein (CRP) and procalcitonin (PCT) emerged as tools to help
clinicians to diagnose infection and to properly initiate and define the duration of antibiotic …

Individualising therapy to minimize bacterial multidrug resistance

AJ Heffernan, FB Sime, J Lipman, JA Roberts - Drugs, 2018 - Springer
The scourge of antibiotic resistance threatens modern healthcare delivery. A contributing
factor to this significant issue may be antibiotic dosing, whereby standard antibiotic regimens …